What is the Return on Assets (ROA) of Orgenesis this year?
The Return on Assets (ROA) of Orgenesis is -3.8 undefined this year.
Orgenesis ROA 2024
Orgenesis ROA
-3.8
Ticker
ORGS
ISIN
US68619K2042
WKN
A2H7XQ
In 2024, Orgenesis's return on assets (ROA) was -3.8, a 2,223.24% increase from the -0.16 ROA in the previous year.
Orgenesis Aktienanalyse
What does Orgenesis do?
Orgenesis Inc is a company specializing in the development of therapies for the treatment of diabetes and other diseases. The company was founded in 2008 to advance research on new therapy approaches for diabetes treatment. Its business model is based on the development of cell therapy technologies to treat patients with diabetes. The company focuses on developing therapies that use human cells to regulate the body's immune system and improve insulin production. Orgenesis Inc also offers consulting services to help other companies develop similar technologies. The company's goal is to provide technology and know-how to drive industrial progress and help people worldwide. Orgenesis Inc is divided into several areas, including biotherapeutics, where it researches and develops therapeutic cell therapies for diabetes and other chronic diseases. It also operates in the engineering services sector, assisting with the design, construction, and development of other therapies and medical devices. The company also distributes products for monitoring diabetes in patients, such as innovative devices that monitor blood glucose and other important parameters, triggering alarms when certain thresholds are exceeded. In summary, Orgenesis Inc is a leading company in the research and development of cell therapy technologies in the field of diabetes and autoimmune therapy. It engages in a wide range of activities, from consulting services to engineering tasks and marketing its own products. This "closed loop" approach of research, development, and marketing has made Orgenesis Inc an innovative company that plays a significant role in the global healthcare industry. Orgenesis ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Orgenesis's Return on Assets (ROA)
Orgenesis's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Orgenesis's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Orgenesis's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Orgenesis’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Orgenesis stock
What was the ROA of Orgenesis compared to the previous year?
The ROA of Orgenesis has increased by 2,223.24% compared to the previous year.
What consequences do high ROA have for investors of Orgenesis?
A high ROA is advantageous for investors of Orgenesis, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Orgenesis?
A low ROA can be unfavorable for investors of Orgenesis as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Orgenesis affect the company?
An increase in ROA of Orgenesis can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Orgenesis impact the company?
A reduction in the ROA of Orgenesis can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Orgenesis?
Some factors that can influence the ROA of Orgenesis include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Orgenesis important for investors?
The ROA of Orgenesis is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Orgenesis take to improve ROA?
To improve ROA, Orgenesis can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Orgenesis pay?
Over the past 12 months, Orgenesis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orgenesis is expected to pay a dividend of 0 USD.
What is the dividend yield of Orgenesis?
The current dividend yield of Orgenesis is .
When does Orgenesis pay dividends?
Orgenesis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Orgenesis?
Orgenesis paid dividends every year for the past 0 years.
What is the dividend of Orgenesis?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Orgenesis located?
Orgenesis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orgenesis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orgenesis from 9/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/7/2024.
When did Orgenesis pay the last dividend?
The last dividend was paid out on 9/7/2024.
What was the dividend of Orgenesis in the year 2023?
In the year 2023, Orgenesis distributed 0 USD as dividends.
In which currency does Orgenesis pay out the dividend?
The dividends of Orgenesis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orgenesis
Our stock analysis for Orgenesis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orgenesis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
